Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
24.75
+0.65 (2.70%)
Feb 27, 2026, 4:00 PM EST - Market closed
AAPG Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AAPG stock have an average target of 48.5, with a low estimate of 45 and a high estimate of 51. The average target predicts an increase of 95.95% from the current stock price of 24.75.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 4, 2025.
Analyst Ratings
The average analyst rating for AAPG stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $45 | Buy | Initiates | $45 | +81.81% | Dec 4, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $51 | Strong Buy | Initiates | $51 | +106.05% | Nov 24, 2025 |
| BTIG | BTIG | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +102.01% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +93.93% | Nov 5, 2025 |
| JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 27, 2025 |
Financial Forecast
Revenue This Year
598.12M
from 980.65M
Decreased by -39.01%
Revenue Next Year
2.80B
from 598.12M
Increased by 368.64%
EPS This Year
-3.14
from -1.34
EPS Next Year
2.37
from -3.14
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 766.5M | 3.4B | ||||
| Avg | 598.1M | 2.8B | ||||
| Low | 499.2M | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -21.8% | 473.3% | ||||
| Avg | -39.0% | 368.6% | ||||
| Low | -49.1% | 198.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | -2.47 | 4.84 | ||
| Avg | -3.14 | 2.37 | ||
| Low | -3.68 | -0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.